Apogee Therapeutics’ $483 Million Common Stock Offering

Gibson, Dunn & Crutcher represented Apogee Therapeutics, Inc. in the offering, and Cooley represented the underwriters.Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company, announced the closing…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now